Together Pharma Ltd

Tel Aviv Stock Exchange TGTR.TA

Together Pharma Ltd EBITDA Margin for the year ending December 31, 2023: 30.35%

Together Pharma Ltd EBITDA Margin is 30.35% for the year ending December 31, 2023, a 165.95% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Together Pharma Ltd EBITDA Margin for the year ending December 31, 2022 was -46.01%, a 9.85% change year over year.
  • Together Pharma Ltd EBITDA Margin for the year ending December 31, 2021 was -51.04%, a -127.87% change year over year.
  • Together Pharma Ltd EBITDA Margin for the year ending December 31, 2020 was 183.15%.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Tel Aviv Stock Exchange: TGTR.TA

Together Pharma Ltd

CEO Mr. Nissim Bracha
IPO Date Aug. 12, 2002
Location Israel
Headquarters Globus Center
Employees 145
Sector Health Care
Industries
Pharmaceuticals Drugstores & Retail Pharmacies
Description

Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email